Search alternatives:
increase decrease » increased release (Expand Search), increased crash (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
increase decrease » increased release (Expand Search), increased crash (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
-
821
KO of iPLA<sub>2</sub>γ attenuates development of albuminuria in STZ-induced diabetic nephropathy.
Published 2024Subjects: -
822
-
823
-
824
-
825
Podocyte numbers in control and iPLA<sub>2</sub>γ KO mice (WT1-positive cells).
Published 2024Subjects: -
826
-
827
-
828
-
829
-
830
-
831
-
832
-
833
-
834
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
835
-
836
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
837
-
838
-
839
-
840
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: